Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
TMEDvsIHEETF Comparison
T. Rowe Price Health Care ETF (TMED) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. TMED's top 3 sector exposures are Health Care and Financials. In contrast, IHE's top sector exposures are Health Care TMED is more expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.38% for IHE. TMED is up 0.13% year-to-date (YTD) with +$3M in YTD flows. IHE performs better with 4.3% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of TMED and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
TMED vs IHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMED IHE | +1.16%-1.82% | +1.57%+5.93% | +0.13%+4.30% | n/a+28.47% | n/a+63.32% | n/a+61.21% |
| Flows | TMED IHE | +$1M+$9M | +$4M+$154M | +$3M+$129M | -+$248M | -+$359M | -+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMED IHE | +16.57%+15.86% | n/a+20.40% | n/a+15.94% | n/a+15.80% |
| Max drawdown | TMED IHE | -7.14%-4.49% | n/a-14.18% | n/a-16.04% | n/a-16.12% |
| Max drawdown duration | TMED IHE | 47d10d | n/a150d | n/a210d | n/a669d |
TMED | IHE | |
Last sale 3/11/2026 at 1:30 PM | $29.57 | $88.40 |
| Previous close 03/11/2026 | $29.70 | $88.62 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TMED | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TMED | IHE | |
|---|---|---|
| Last price | $29.57 | $88.40 |
| 1D performance | -0.42% | -0.25% |
| AuM | $19.32 M | $1.02 B |
| E/R | 0.44% | 0.38% |
TMED | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 74 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2025 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the TMED and IHE ETFs performed in 2026?
As of March 10, 2026, TMED is up 0.13% year-to-date (YTD), while IHE has returned 4.3%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: TMED or IHE?
Year-to-date, the TMED ETF saw +$3M in flows, compared to +$129M for IHE.
Which ETF is bigger: TMED or IHE?
As of March 10, 2026, TMED holds $19.32 M in assets under management (AUM), while IHE manages $1.02 B.
What sectors do the TMED and IHE ETFs invest in?
TMED leans toward sectors like Health Care. Meanwhile, IHE focuses on Health Care.
What are the top holdings of the TMED ETF and IHE ETF?
TMED top holdings include LILLY, UNITEDHEALTH GRP and GILEAD SCIENCES. IHE holds in its top three: JOHNSON&JOHNSON, LILLY and MERCK & CO INC.
Which ETF is more diversified: TMED or IHE?
TMED holds 80 securities with 56.46% of its assets in the top 15. IHE has 56 securities and a top 15 weight of 84.8%.
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
Healthcare Stocks Rebound
Health is Wealth: A look at the Healthcare Sector
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
